tiprankstipranks
Analyst Profile
Followed by 200 other investors
.
Kyle Rose

Kyle Rose

Canaccord Genuity
Wall Street Analyst
Ranked #368 out of 8,054 Analysts on TipRanks (#488 out of 21,594 overall experts)

Success Rate

51%
196 out of 386 Profitable Transactions

Average Return

15.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Kyle Rose's ratings since 2013 and opened each position for the duration of 1 Year:
50.78% of your transactions would have been profitable with an average return of 15.2%

Stock Rating Distribution

751Ratings
84.55% Buy
15.31% Hold
0.13% Sell
Distribution of Kyle Rose's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market
United KingdomUK Market
CanadaCanadian Market

Best Rating

Stock:
Inmode
(INMD)
Rating Type:Buy
Dates:Nov 12, 2020 - Nov 12, 2021
Gain:357.00%
The most profitable rating made by Kyle Rose

Kyle Rose's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
~RSLS
ReShape Lifesciences
Oct 08, 2013
Buy
Reiterated
0.00%
1
~SPIR
Spire
Jun 07, 2016
Buy
Assigned
0.00%
1
ZLTQ
Zeltiq Aesthetics
Mar 09, 2017
Hold
Reiterated
100%
+39.90%
15
ENTL
Entellus Medical
Dec 08, 2017
Hold
Reiterated
0%
-28.75%
26
NXTM
NxStage Medical
Feb 22, 2018
Hold
Reiterated
100%
+21.58%
19
Ocugen
Jun 26, 2018
Buy
Reiterated
$4.00
(56.25% Upside)
36%
-19.64%
15
Rewalk Robotics
Aug 17, 2018
Buy
Reiterated
$31.25
(2848.11% Upside)
0%
-56.30%
17
Senseonics Holdings
Apr 22, 2020
Hold
Reiterated
$0.75
(-61.93% Downside)
44%
-1.62%
38
ReShape Lifesciences
May 08, 2020
Hold
Reiterated
0%
-54.46%
20
Profound Medical
Mar 08, 2021
Buy
Initiated
C$29.56
(213.45% Upside)
0%
-61.00%
1
List of latest recommendations made by Kyle Rose. Click to expand and see Kyle Rose's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More